Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: CA186241
National Institute of General Medical Sciences
Grant: GM130604
NIGMS NIH HHS
Grant: R01 GM130604
NCI NIH HHS
Grant: R01 CA186241
National Institutes of Health
Grant: 1R01GM130604-01A1
Novel roles for USP36 in ribosome biogenesis
National Institutes of Health
Grant: 5R01CA196228-03
The Role of post-translational activation of Myc in pancreatic cancer
National Institutes of Health
Grant: 5U01CA224012-04
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens
National Institutes of Health
Grant: 3U54CA209988-03S1
Measuring, Modeling and Controlling Heterogeneity
National Institutes of Health
Grant: 5R01CA186241-09
DeSUMOylation regulation of c-Myc
National Cancer Institute
FWCI
2.37
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals